Understanding India's New Patent Laws - Did the 2005 Patents Act engender a Western intellectual property rights culture in the country? - BioPharm International


Understanding India's New Patent Laws
Did the 2005 Patents Act engender a Western intellectual property rights culture in the country?

BioPharm International
Volume 21, Issue 4


1. Wong J, et al. Harnessing the power of India. BCG Focus. 2006 May.

2. India biopharma product pipeline swells. BioSpectrumAsia. 2007 Nov 26.

3. Buchanan JM. Pharmaceutical patents in India: new and old compulsory license provisions cast doubt on their value. Available from http://www.promotetheprogress.com/archives/2005/09/pharmaceutical.html

4. The Patents (Amendment) Act, 2005. Available from patentoffice.nic.in/ipr/patent/patent_2005.pdf.

5. McNeil D. Indian company to make generic version of flu drug Tamiflu. New York Times. 2005 Oct 14.

6. Gerhardsen T. Indian industry pushing for compulsory licensing for Tamiflu. Intellectual Property Watch. 2007 Oct 25.

7. Srinivasan S. Battling patent laws: the Glivec case. Economic and Political Weekly. 2007 Sept 15;3686–90.

8. Mueller J. Taking TRIPS to India—Novartis, patent law, and access to medicines. New Eng J Med. 2007 Feb 8;346:541–43.

9. Lingh S, et al. Viread: the next pre-grant opposition target. 2006 May 23. Available from http://www.patentcircle.blogspot.com/2006/05/viread-next-pre-grant-opposition.html.

10. Factor M, Indian generic pharma companies delay patent protection by pre grant opposition proceedings. The IP Factor. 2006 Oct 25. Available from http://www.blog.ipfactor.co.il/2006/10/25/indian-generic-pharma-companies-delay-patent-protection-by-pre-grant-opposition-proceedings/

11. Gentleman A, H Kumar. AIDS groups in India sue to halt patent for US drug. New York Times. 2006 May 12.

12. Smith A, India's elephant in the room: weak patent laws. http://CNN-Money.com/. 2007 May 4. Available from http://www.money.cnn.com/2007/05/04/news/companies/india_biotech/index.htm (accessed 20 Oct 2007).

13. US Official Slams India's IP Laws. Managing Intellectual Property. 2006 Dec 11. Available from http://www.managingip.com/Article.aspx?ArticleID=1257511

14. Clearstate Pte. Ltd. Biotech: India's new global pitch. 2007 July 23. Available from http://www.clearstate.com/admin/data/Clearstate_India_Biotech.pdf

15. Finston S. Technology transfer: impact and importance for Indian biotechnology growth. Advances in Biopharmaceutical Technology in India, ed. E Langer.

16. China, Russia upbraided in global intellectual property watchlist. Global Insight. Available from http://www.globalinsight.com/.

17. Chhonkar V. India retained on US 'Special 301' watch list. Patent Circle. 2006 May 2. Available from http://www.patentcircle.blogspot.com/2006/05/india-retained-on-us-special-301-watch.html.

18. USTR priority watch list. Available from http://www.ustr.gov/assets/Document_Library/Reports_Publications/2007/2007_Special_301_Review/asset_upload_file884_11123.pdf.

blog comments powered by Disqus



GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here